Lilly Delivers First-Quarter 2021 Financial Results, Adjusts 2021 Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall Street ends higher as tech rebounds before Nvidia results
- Oil settles down more than 3%; investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Wall Street ends higher as tech rebounds before Nvidia results
- Oppenheimer Upgrades Capricor Therapeutics (CAPR) to Outperform 'on Approval Optimism'
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Dick's Sporting Goods (DKS) Misses Q2 EPS by 25c, Offers Guidance
Eli Lilly & Co. (LLY) Misses Q1 EPS by 27c, Lowers FY EPS Guidance
April 27, 2021 6:28 AM EDTEli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.87, $0.27 worse than the analyst estimate of $2.14. Revenue for the quarter came in at $6.81 billion versus the consensus estimate of $7.02 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2021 EPS of $7.80-$8.00, versus the consensus of... More
